drugset / Trial / NCT00545142
Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To demonstrate the efficacy and safety of co-administration of Abilify(aripiprazole) with Depakote(divalproate) in the acute phase of 6-week treatment of acute mania in patients with bipolar disorder.
Timeline
- Start
- 2007-10
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | — | — |
| Subject | Divalproate | Unknown | — | — |